Christopher Richard Anzalone sold $775K of Arrowhead Pharmaceuticals (ARWR)

Executed Mar 13 2025, disclosed Mar 17 2025, 4 days later.

Value, as filed

$775K

51,425 sh × $15.07

Executed

Mar 13 2025

the trade date, as filed

Disclosed

Mar 17 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Christopher Richard Anzalone Chief Executive Officer profile →

Christopher Richard Anzalone (Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $12.2M of ARWR (181,832 sh across 9 lots, as filed), executed Dec 15 2025.

The name

ARWR

Arrowhead Pharmaceuticals, Inc. ARWR · Healthcare · 34 filings in 24 months ticker →

Healthcare · Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christopher Richard Anzalone in ARWR

ARWRSALE Arrowhead Pharmaceuticals, Inc. $872K
13,187 sh across 2 lots
Exec Jan 2
Filed Jan 5 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. $3.6M
51,726 sh across 2 lots
Exec Dec 29 2025
Filed Dec 30 2025 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. $1.7M
24,712 sh across 4 lots
Exec Dec 19 2025
Filed Dec 23 2025 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. $5.4M
84,018 sh across 3 lots
Exec Dec 17 2025
Filed Dec 19 2025 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. $12.2M
181,832 sh across 9 lots
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. $1.5M
136,105 sh across 3 lots
Exec Apr 9 2025
Filed Apr 11 2025 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. $5.3M
300,000 sh across 2 lots
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. $219K
11,520 sh × $19.05
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET